Citrulline malate is a compound combining the amino acid L-citrulline with malate (malic acid), typically in a 2:1 or 1:1 ratio. It works by enhancing nitric oxide production to improve blood flow, supporting the urea cycle to reduce ammonia buildup, and potentially increasing ATP production through malate's role in the Krebs cycle. Primarily used as an ergogenic aid for resistance training and high-intensity exercise performance.

Overview

Citrulline malate is a salt formed by combining L-citrulline with malic acid, typically in a 2:1 ratio. This combination was originally developed to address fatigue and asthenia in clinical settings, and it has since become one of the most widely used pre-workout supplements in sports nutrition. The rationale for combining these two compounds is that citrulline supports nitric oxide production and ammonia clearance through the urea cycle, while malate participates in the tricarboxylic acid (TCA) cycle to support aerobic ATP generation.

Research on citrulline malate has shown benefits for both resistance and endurance exercise. A frequently cited study demonstrated that 8 g of citrulline malate taken before resistance training significantly increased the number of repetitions performed and reduced post-exercise muscle soreness by up to 40%. The supplement appears to enhance performance by improving ammonia recycling, supporting oxidative ATP production, and increasing blood flow to working muscles through nitric oxide-mediated vasodilation.

The standard recommended dose is 6–8 g of citrulline malate (2:1 ratio) taken approximately 30–60 minutes before exercise. It is important to verify the ratio when selecting products, as some formulations provide a 1:1 ratio, which delivers less active citrulline per serving. Citrulline malate is generally well-tolerated, with gastrointestinal discomfort being the most commonly reported side effect at higher doses. It is often stacked with beta-alanine and creatine in comprehensive pre-workout formulations.

Mechanism of Action

Dual-Action Ergogenic — Citrulline + TCA Cycle Anaplerosis

Citrulline malate is a 1:1 or 2:1 molar combination of L-citrulline and DL-malic acid (malate), designed to synergistically enhance exercise performance through complementary metabolic pathways. The citrulline component sustains nitric oxide production via the renal arginine-citrulline recycling pathway, while the malate component provides a tricarboxylic acid (TCA) cycle anaplerotic substrate that replenishes oxaloacetate (OAA) through the malate-aspartate shuttle, maintaining aerobic ATP production when TCA intermediates are depleted during high-intensity exercise (PMID: 12145119).

Malate Dehydrogenase & Aerobic Energy Production

Malate enters the mitochondrial matrix via the dicarboxylate carrier and is oxidized to oxaloacetate by malate dehydrogenase (MDH2), generating NADH that feeds complex I of the electron transport chain. OAA then condenses with acetyl-CoA (from fatty acid oxidation and pyruvate dehydrogenase) via citrate synthase, sustaining TCA cycle flux. During intense exercise, TCA intermediates are depleted through cataplerotic reactions (glutamate transamination, amino acid synthesis), and malate supplementation restores the OAA pool, preventing the metabolic bottleneck that limits aerobic ATP regeneration (PMID: 21799861).

Ammonia Clearance & Acid-Base Balance

The combined citrulline-malate formulation accelerates ammonia detoxification through enhanced urea cycle flux (citrulline-mediated) and improved hepatic gluconeogenesis from lactate (malate-mediated). Citrulline malate reduces blood ammonia levels by 15-30% during exhaustive exercise, attenuating central fatigue mediated by ammonia-induced glutamine accumulation in astrocytes. The malate component also participates in the malate-aspartate shuttle, transferring cytoplasmic NADH equivalents into mitochondria for oxidative phosphorylation (PMID: 20386132).

Clinical Exercise Performance Evidence

A landmark study by Bendahan et al. demonstrated that 6 g citrulline malate daily increased oxidative ATP production by 34%, reduced phosphocreatine recovery time by 20%, and increased total work output during repeated high-intensity cycling bouts, supporting its role as an ergogenic aid for resistance and high-intensity interval training (PMID: 12145119).

Reconstitution Calculator

Research

Safety Profile

Safety Profile: Citrulline Malate

Common Side Effects

• Gastrointestinal discomfort: the most frequent complaint—stomach upset, mild nausea, heartburn, and diarrhea, primarily attributed to the malic acid component
• Bloating and flatulence, especially at doses above 6 g/day
• Mild headache (possibly related to nitric oxide–mediated vasodilation)
• Altered urine odor (harmless)

Serious Adverse Effects

• Hypotension: citrulline is converted to arginine, which increases nitric oxide production; in individuals on antihypertensives or PDE5 inhibitors, clinically significant blood pressure drops may occur
• Hyperargininemia risk: in rare genetic arginine metabolism disorders (arginase deficiency), citrulline supplementation could exacerbate arginine accumulation and neurotoxicity
• Renal considerations: while generally safe for healthy kidneys, high-dose citrulline increases the nitrogen load; theoretical concern in advanced CKD
• No organ toxicity has been observed in clinical trials at doses up to 15 g/day for short durations

Contraindications

• Known allergy to citrulline or malic acid
• Arginase deficiency or other urea cycle disorders
• Concurrent use of nitrates (nitroglycerin) or PDE5 inhibitors (sildenafil, tadalafil)—risk of severe hypotension
• Severe hypotension (systolic <90 mmHg)

Drug Interactions

• PDE5 inhibitors (sildenafil, tadalafil, vardenafil): significantly amplified vasodilation and hypotensive risk—avoid concurrent use without medical clearance
• Antihypertensives (ACE inhibitors, ARBs, calcium channel blockers): additive blood pressure reduction; monitor BP when initiating citrulline
• Nitrate medications (isosorbide, nitroglycerin): dangerous hypotension possible via shared NO pathway
• Arginine supplements: redundant—citrulline is converted to arginine; stacking increases GI side effects without proportional benefit
• Anticoagulants: some in vitro evidence of mild antiplatelet activity; clinical significance is low but worth noting

Population-Specific Considerations

• Athletes / exercise performance: best-studied population; 6–8 g citrulline malate (2:1 ratio) taken 40–60 minutes pre-workout is well-tolerated; GI issues are the main limiting factor
• Heart failure patients: promising for improving exercise tolerance; 3 g/day showed benefit in pilot studies; use under cardiologist supervision due to hemodynamic effects
• Pregnancy / lactation: no safety data for supplemental doses; L-citrulline is a normal amino acid in watermelon and diet, but concentrated supplements should be avoided
• Elderly: may benefit vascular health; start at 3 g/day; monitor blood pressure
• Kidney disease: mild-moderate CKD—limited data; consult nephrologist before use; avoid in dialysis patients
• Children: no established dosing; some research in sickle cell disease pediatric populations but not standard practice

Pharmacokinetic Profile